Table 1.
To summarize the mechanism of IL-17 in different diseases
Disease | Mechanism | Refs |
---|---|---|
Aortic dissection | Reduced endothelial progenitor cells partly related to upregulated IL-6/IL-17 through DiI-acLDL/lectin and CD34+KDR+ cells | [161] |
Cardiovascular diseases with (dyslipidemia, hypertension and diabetes mellitus) | Enhancement of IL-17 /IFN-γ production of CD4+28nullNKG2D+ T cells | [162] |
Type 2 Diabetes Mellitus | IL-10/IL-17 correlated negatively with BMI or metabolic index | [163] |
Preeclampsia | Mediated placental ischaemia and oxidative stress though AT1-AA production | [164, 165] |
Idiopathic pulmonary arterial hypertension | TH17 cell immune polarization and IL-17A with disease severity or outcome associated conditions | [166, 167] |
Systemic sclerosis | Activation of Th17 and Th1 cell responses | [168] |
Schistosomiasis japonica | Activation of γδT cells and producing IL-17 against parasite eggs | [169] |